Comparative cardiovascular outcomes in type 2 diabetes patients taking dapagliflozin versus empagliflozin: a nationwide population-based cohort study

被引:0
|
作者
Jaehyun Lim
You-Jung Choi
Bong Sung Kim
Tae-Min Rhee
Hyun-Jung Lee
Kyung-Do Han
Jun-Bean Park
Jin Oh Na
Yong-Jin Kim
Heesun Lee
Hyung-Kwan Kim
机构
[1] Seoul National University Hospital,Department of Internal Medicine
[2] Seoul National University College of Medicine,Department of Internal Medicine
[3] Korea University College of Medicine,Division of Cardiology, Department of Internal Medicine
[4] Soongsil University,Department of Statistics and Actuarial Science
[5] Seoul National University Hospital Healthcare System Gangnam Center,Division of Cardiology, Department of Internal Medicine
[6] Seoul National University College of Medicine,Diagnostic Test Unit Section of Cardiovascular Imaging, Division of Cardiology, Cardiovascular Center, Department of Internal Medicine, Seoul National University Hospital,
来源
关键词
Sodium-glucose co-transporter-2 inhibitors ; Dapagliflozin; Empagliflozin; Cardiovascular risk; Heart failure; Cardiovascular death;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [31] Dipstick proteinuria and risk of type 2 diabetes mellitus: a nationwide population-based cohort study
    Jimin Jeon
    Jinkwon Kim
    [J]. Journal of Translational Medicine, 19
  • [32] Remnant Cholesterol Is an Independent Predictor of Type 2 Diabetes: A Nationwide Population-Based Cohort Study
    Huh, Ji Hye
    Kang, Jun Goo
    [J]. DIABETES CARE, 2023, 46 (10) : E205 - E206
  • [33] Remnant Cholesterol Is an Independent Predictor of Type 2 Diabetes: A Nationwide Population-Based Cohort Study
    Huh, Ji Hye
    Roh, Eun
    Lee, Seong Jin
    Ihm, Sung-Hee
    Han, Kyung-Do
    Kang, Jun Goo
    [J]. DIABETES CARE, 2023, 46 (02) : 305 - 312
  • [34] Dipstick proteinuria and risk of type 2 diabetes mellitus: a nationwide population-based cohort study
    Jeon, Jimin
    Kim, Jinkwon
    [J]. JOURNAL OF TRANSLATIONAL MEDICINE, 2021, 19 (01)
  • [35] Empagliflozin versus dapagliflozin for primary prevention of heart failure in patients with type 2 diabetes
    Arbel, R. Ronen
    Aboalhasan, E.
    Hammerman, A.
    Azuri, J.
    [J]. EUROPEAN JOURNAL OF HEART FAILURE, 2020, 22 : 95 - 95
  • [36] Adverse Outcomes After Noncardiac Surgery in Patients With Diabetes A nationwide population-based retrospective cohort study
    Yeh, Chun-Chieh
    Liao, Chien-Chang
    Chang, Yi-Cheng
    Jeng, Long-Bin
    Yang, Horng-Ren
    Shih, Chun-Chuan
    Chen, Ta-Liang
    [J]. DIABETES CARE, 2013, 36 (10) : 3216 - 3221
  • [37] Associations between Cardiovascular Outcomes and Rheumatoid Arthritis: A Nationwide Population-Based Cohort Study
    Kang, Seonyoung
    Han, Kyungdo
    Jung, Jin-Hyung
    Eun, Yeonghee
    Kim, In Young
    Hwang, Jiwon
    Koh, Eun-Mi
    Lee, Seulkee
    Cha, Hoon-Suk
    Kim, Hyungjin
    Lee, Jaejoon
    [J]. JOURNAL OF CLINICAL MEDICINE, 2022, 11 (22)
  • [38] Cardiovascular Safety in Type 2 Diabetes With Sulfonylureas as Second-line Drugs: A Nationwide Population-Based Comparative Safety Study
    Wang, Huan
    Cordiner, Ruth L. M.
    Huang, Yu
    Donnelly, Louise
    Hapca, Simona
    Collier, Andrew
    McKnight, John J.
    Kennon, Brian R.
    Gibb, Fraser R.
    McKeigue, Paul
    Wild, Sarah
    Colhoun, Helen
    Chalmers, John
    Petrie, John
    Sattar, Naveed
    MacDonald, Thomas
    McCrimmon, Rory
    Morales, Daniel
    Pearson, Ewan
    [J]. DIABETES CARE, 2023, 46 (05) : 967 - 977
  • [39] Sulfonylureas and the Risk of Adverse Cardiovascular Events Among Patients with Type 2 Diabetes: A Population-Based Cohort Study
    Filion, Kristian B.
    Azoulay, Laurent
    Yin, Hui
    Yu, Oriana H.
    Suissa, Samy
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2017, 26 : 46 - 46
  • [40] Real-World Comparative Effectiveness of Canagliflozin Versus Empagliflozin and Dapagliflozin in Patients with Type 2 Diabetes in the United States
    Blonde, Lawrence
    Patel, Charmi
    Wu, Bingcao
    Chen, Yen-Wen
    Pericone, Christopher D.
    Bookhart, Brahim
    [J]. ADVANCES IN THERAPY, 2021, 38 (01) : 594 - 606